FDA approves new drug for thyroid cancer
On February 13, the U.S. Food and Drug Administration (FDA) approved Lenvima (lenvatinib) to treat patients with progressive, differentiated thyroid cancer whose disease progressed…
Web Exclusives
Exercise for patients with type 2 diabetes most effective after dinner
Performing resistance exercise to reduce the risk of cardiovascular disease in obese patients with type 2 diabetes is most effective when done after dinner,…
New HPV vaccine offers greater protection against cervical cancer
A study in The New England Journal of Medicine Scientists reports that a new HPV (human papilloma virus) vaccine protects against nine types of…
FDA approves Lucentis to treat diabetic retinopathy
On February 6, the U.S. Food and Drug Administration (FDA) expanded the approved use for Lucentis (ranibizumab injection) 0.3 mg to treat diabetic retinopathy…
New sleep recommendations
A panel convened by the National Sleep Foundation has issued recommendations for sleep based on age. The recommendation for young adults and adults is…
FDA approves first generic version of Nexium
On January 26, the U.S. Food and Drug Administration (FDA) approved the first generic version of Nexium (esomeprazole magnesium delayed-release capsules) to treat gastroesophageal…
FDA permits marking of mobile app for glucose monitoring
On January 23, the U.S. Food and Drug Administration (FDA) permitted marketing of the first set of mobile medical apps that allow people with…
Smoking may increase risks for patients receiving therapy for prostate cancer
Among patients with prostate cancer, those who smoke have increased risks of experiencing side effects from treatment and of developing future cancer recurrences, or…
FDA approves Ibrance for postmenopausal women with metastatic breast cancer
On February 3, the U.S. Food and Drug Administration (FDA) approved Ibrance (palbociclib) to treat advanced metastatic breast cancer. Read more.
FDA approves tissue adhesive for internal use
On February 4, the U.S. Food and Drug Administration (FDA) approved TissuGlu, the first tissue adhesive approved for internal use. TissuGlu is a urethane-based…
FDA to strengthen review of AEDs
On January 28, the U.S. Food and Drug Administration (FDA) announced that it will strengthen its review of automated external defibrillators (AEDs) to help…
Surgary drinks can prompt early onset of menstruation
Girls who frequently consume sugary drinks tend to start their menstrual periods earlier than girls who do not, according to a study in Human…
FDA approves new drug for thyroid cancer
On February 13, the U.S. Food and Drug Administration (FDA) approved Lenvima (lenvatinib) to treat patients with progressive, differentiated thyroid cancer whose…
Exercise for patients with type 2 diabetes most effective after dinner
Performing resistance exercise to reduce the risk of cardiovascular disease in obese patients with type 2 diabetes is most effective when done…
New HPV vaccine offers greater protection against cervical cancer
A study in The New England Journal of Medicine Scientists reports that a new HPV (human papilloma virus) vaccine protects against nine…
FDA approves Lucentis to treat diabetic retinopathy
On February 6, the U.S. Food and Drug Administration (FDA) expanded the approved use for Lucentis (ranibizumab injection) 0.3 mg to treat…
New sleep recommendations
A panel convened by the National Sleep Foundation has issued recommendations for sleep based on age. The recommendation for young adults and…
FDA approves first generic version of Nexium
On January 26, the U.S. Food and Drug Administration (FDA) approved the first generic version of Nexium (esomeprazole magnesium delayed-release capsules) to…
FDA permits marking of mobile app for glucose monitoring
On January 23, the U.S. Food and Drug Administration (FDA) permitted marketing of the first set of mobile medical apps that allow…
Smoking may increase risks for patients receiving therapy for prostate cancer
Among patients with prostate cancer, those who smoke have increased risks of experiencing side effects from treatment and of developing future cancer…
FDA approves Ibrance for postmenopausal women with metastatic breast cancer
On February 3, the U.S. Food and Drug Administration (FDA) approved Ibrance (palbociclib) to treat advanced metastatic breast cancer. Read more.
FDA approves tissue adhesive for internal use
On February 4, the U.S. Food and Drug Administration (FDA) approved TissuGlu, the first tissue adhesive approved for internal use. TissuGlu is…
FDA to strengthen review of AEDs
On January 28, the U.S. Food and Drug Administration (FDA) announced that it will strengthen its review of automated external defibrillators (AEDs)…
Surgary drinks can prompt early onset of menstruation
Girls who frequently consume sugary drinks tend to start their menstrual periods earlier than girls who do not, according to a study…
Poll
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.